The distinct enrichment of immune pathways—such as HIF-1-driven metabolic adaptations in ACO and NET formation in COPD—provides valuable insights into the underlying mechanisms, offering potential guidance for future phenotype-specific research and therapeutic interventions. Here, HIF1A is linked to chronic obstructive pulmonary disease.